As global vaccine players rush to deliver Covid -19 vaccines, Russia’s first batch of Sputnik V vaccination developed by Gamaleya national Research center of Epidemiology and Microbiology and the Russian direct investment fund has been released in civil circulation, regional deliveries are planned in the near future, the Russian health ministry informed.
News Agency ANI reported that the first batch of COVID-19 vaccine Sputnik V was dispatched for civil circulation on Tuesday.
This comes a month after Russia became the first country to approve the public use of a Coronavirus vaccine the Russian health ministry registered the first vaccine against COVID-19, named Sputnik V, on August 11.
Moscow Mayor Sergey Sobyanin expressed hope on Sunday that the majority of the Russian capital’s residents will be vaccinated against the coronavirus within several months.
The ministry of Russia said in a statement,
The first batch of the ‘Gam-COVID-Vac’ (Sputnik V) vaccine for the prevention of the new coronavirus infection, developed by the Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of Russia, has passed the necessary quality tests in the laboratories of Roszdravnadzor (medical device regulator) and has been released into civil circulation,”.
According to reports of news agency ANI,
Kirill Dmitriev the CEO of the Russian direct investment fund confirmed on Monday that,” the clinical trials in Saudi Arabia, United Arab Emirates (UAE), the Philippines, India and Brazil will begin this month [September]”.
Dmitriev further added that,
The post-registration studies involving more than 40,000 people started in Russia on August 26, before AstraZeneca started its Phase 3 trial in the US with 30,000 participants. Clinical trials in Saudi Arabia, the United Arab Emirates (UAE), the Philippines, India, and Brazil will begin this month. The preliminary results of the Phase 3 trial will be published in October-November 2020,”.
